Bharat Heavy Electricals Limited Biochemistry Reagent Kit for Human Samples Tender 2025 India

Tender Overview

Bharat Heavy Electricals Limited (BHEL) invites bids for a Biochemistry Reagent Kit for Human Samples under the Department of Heavy Industry framework in India. The procurement includes a reagent kit per pack with a calibrator and control, noting the total volume per pack and sample compatibility. The tender emphasizes payment terms aligned to MSME categories and a risk-managed contract framework, with enforcement provisions to recover 10% contract value in cases of breach. The absence of a BOQ items breakdown suggests a consolidated supply scope, likely spanning multiple packs or batches, contingent on the final contract structure. This opportunity is positioned within India’s public procurement ecosystem where quality controls and supplier performance will influence award decisions.

Technical Specifications & Requirements

• Product category: Biochemistry reagent kit for human samples; includes calibrator and control per pack; supported type of sample and type of test details are stated in data fields.
• Form of reagent at delivery and total volume per pack are specified; ensure packaging aligns with specified volumes and shelf life.
• Other technical placeholders indicate need for packaging and compatibility information, with potential emphasis on reagent stability, storage conditions, and batch traceability. Suppliers should prepare documentation showing willingness to provide per-pack calibration controls matching the buyer’s testing protocols.
• Delivery readiness: confirm packaging format and supply continuity for the expected demand cycle while preserving reagent integrity during transit.

Terms, Conditions & Eligibility

• Payment terms depend on MSME status: Micro & Small Enterprises paid within 45 days, Medium Enterprises within 60 days, Non‑MSMEs within 90 days after receipt and acceptance per MSME act.
• BHEL contract remedies include encashment of security instruments (minimum 10% of contract value) and stepwise recovery from other financial remedies for breach; non-performance may trigger LD, debarment, or de-scoping.
• Suspension of business dealings is enforceable for malpractices or bid manipulation per BHEL guidelines; conflict of interest and OEM sourcing conditions are highlighted, with a preference for direct manufacturer procurement where feasible.
• Documentation and eligibility criteria are enforced via standard procurement governance; ensure alignment with BHEL’s supplier guidelines and anti-corruption measures.